Position in ASND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,558,953
+$3,660,132 QoQ
Shares Held
98,627
+11.3% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
11.87%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Resolute Capital Asset Partners LLC holds $27,245,478 across 4 Biotechnology names. ASND ranks #1 (82.8% of the industry book) .
All Filings in ASND
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,558,953 | 98,627 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,898,821 | 88,627 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $32,937,250 | 165,672 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,731,987 | 160,672 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,106,550 | 167,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,763,215 | 114,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,602,895 | 104,500 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,409,860 | 47,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,104,990 | 47,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,584,580 | 36,400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,511,500 | 37,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,346,875 | 37,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,020,750 | 37,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,579,875 | 37,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,097,800 | 30,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,859,200 | 20,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,347,200 | 20,000 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||